Role of the colony-stimulating factor (CSF)/CSF-1 receptor axis in cancer

Biochemical Society Transactions

Volumn 44, Issue 2, 2016, Pages 333-341

  Achkova, Daniela ^a   Maher, John ^a,b,c  

^a GUY S HOSPITAL   (United Kingdom)

^b BARNET HOSPITAL   (United Kingdom)

^c KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

c fms; Cancer; Clinical prognostic factors; Colony stimulating factor 1; Colony stimulating factor 1 receptor; Tumour progression

Indexed keywords

COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 34; COLONY STIMULATING FACTOR; LIGAND;

BONE MARROW CELL; BREAST CANCER; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CLASSICAL HODGKIN LYMPHOMA; CYTOKINE RELEASE; HUMAN; MALIGNANT NEOPLASM; MALIGNANT TRANSFORMATION; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; CHEMISTRY; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY;

COLONY-STIMULATING FACTORS; HUMANS; LIGANDS; NEOPLASMS; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR;

EID: 85009752477     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20150245     Document Type: Review

References (92)

1. Sherr, C.J., Rettenmier, C.W., Sacca, R., Roussel, M.F., Look, A.T. and Stanley, E.R. (1985) The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41, 665-676
2. Lin, H., Lee, E., Hestir, K., Leo, C., Huang, M., Bosch, E., Halenbeck, R., Wu, G., Zhou, A., Behrens, D. et al. (2008) Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320, 807-811
3. Yarden, Y., Kuang, W.J., Yang-Feng, T., Coussens, L., Munemitsu, S., Dull, T.J., Chen, E., Schlessinger, J., Francke, U. and Ullrich, A. (1987) Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 6, 3341-3351
4. Rosnet, O., Schiff, C., Pebusque, M.J., Marchetto, S., Tonnelle, C., Toiron, Y., Birg, F. and Birnbaum, D. (1993) Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood 82, 1110-1119
5. Claesson-Welsh, L., Eriksson, A., Westermark, B. and Heldin, C.H. (1989) cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF) receptor establishes structural similarity to the B-type PDGF receptor. Proc. Natl. Acad. Sci. U.S.A. 86, 4917-4921
6. Yarden, Y., Escobedo, J.A., Kuang, W.J., Yang-Feng, T.L., Daniel, T.O., Tremble, P.M., Chen, E.Y., Ando, M.E., Harkins, R.N., Francke, U. et al. (1986) Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature 323, 226-232
7. Hubbard, S.R. and Till, J.H. (2000) Protein tyrosine kinase structure and function. Annu. Rev. Biochem. 69, 373-398
8. van der Geer, P and Hunter, T. (1990) Identification of tyrosine 706 in the kinase insert as the major colony-stimulating factor 1 (CSF-1)-stimulated autophosphorylation site in the CSF-1 receptor in a murine macrophage cell line. Mol. Cell. Biol. 10, 2991-3002
9. Tapley, P., Kazlauskas, A., Cooper, J.A. and Rohrschneider, L.R. (1990) Macrophage colony-stimulating factor-induced tyrosine phosphorylation of c-fms proteins expressed in FDC-P1 and BALB/c 3T3 cells. Mol. Cell. Biol. 10, 2528-2538
10. Reedijk, M., Liu, X., van der Geer, P., Letwin, K., Waterfield, M.D., Hunter, T. and Pawson, T. (1992) Tyr721 regulates specific binding of the CSF-1 receptor kinase insert to PI 3′-kinase SH2 domains: a model for SH2-mediated receptor-target interactions. EMBO J. 11, 1365-1372
11. Rohrschneider, L.R., Bourette, R.P., Lioubin, M.N., Algate, P.A., Myles, G.M. and Carlberg, K. (1997) Growth and differentiation signals regulated by the M-CSF receptor. Mol. Reprod. Dev. 46, 96-103
12. Yu, W., Chen, J., Xiong, Y., Pixley, F.J., Dai, X.M., Yeung, Y.G. and Stanley, E.R. (2008) CSF-1 receptor structure/function in MacCsf1r-/- macrophages: regulation of proliferation, differentiation, and morphology. J. Leukoc. Biol. 84, 852-863
13. Walter, M., Lucet, I.S., Patel, O., Broughton, S.E., Bamert, R., Williams, N.K., Fantino, E., Wilks, A.F. and Rossjohn, J. (2007) The 2.7 A crystal structure of the autoinhibited human c-Fms kinase domain. J. Mol. Biol. 367, 839-847
14. Xiong, Y., Song, D., Cai, Y., Yu, W., Yeung, Y.G. and Stanley, E.R. (2011) A CSF-1 receptor phosphotyrosine 559 signaling pathway regulates receptor ubiquitination and tyrosine phosphorylation. J. Biol. Chem. 286, 952-960
15. Yu, W., Chen, J., Xiong, Y., Pixley, F.J., Yeung, Y.G. and Stanley, E.R. (2012) Macrophage proliferation is regulated through CSF-1 receptor tyrosines 544, 559, and 807. J. Biol. Chem. 287, 13694-13704
16. Shurtleff, S.A., Downing, J.R., Rock, C.O., Hawkins, S.A., Roussel, M.F. and Sherr, C.J. (1990) Structural features of the colony-stimulating factor 1 receptor that affect its association with phosphatidylinositol 3-kinase. EMBO J. 9, 2415-2421
17. Baccarini, M., Sabatini, D.M., App, H., Rapp, U.R. and Stanley, E.R. (1990) Colony stimulating factor-1 (CSF-1) stimulates temperature dependent phosphorylation and activation of the RAF-1 proto-oncogene product. EMBO J. 9, 3649-3657
18. Stanley, E.R. and Chitu, V. (2014) CSF-1 receptor signaling in myeloid cells. Cold Spring Harb. Perspect. Biol. 6, 1-21
19. Fixe, P. and Praloran, V. (1998) M-CSF: haematopoietic growth factor or inflammatory cytokine? Cytokine 10, 32-37
20. Visvader, J. and Verma, I.M. (1989) Differential transcription of exon 1 of the human c-fms gene in placental trophoblasts and monocytes. Mol. Cell Biol. 9, 1336-1341
21. Pixley, F.J. and Stanley, E.R. (2004) CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol. 14, 628-638
22. Fixe, P., Rougier, F., Ostyn, E., Gachard, N., Faucher, J.L., Praloran, V. and Denizot, Y. (1997) Spontaneous and inducible production of macrophage colony-stimulating factor by human bone marrow stromal cells. Eur. Cytokine Netw. 8, 91-95
23. Nohava, K., Malipiero, U., Frei, K. and Fontana, A. (1992) Neurons and neuroblastoma as a source of macrophage colony-stimulating factor. Eur. J. Immunol. 22, 2539-2545
24. Praloran, V., Chevalier, S. and Gascan, H. (1992) Macrophage colony-stimulating factor is produced by activated T lymphocytes in vitro and is detected in vivo in T cells from reactive lymph nodes. Blood 79, 2500-2501
25. Praloran, V. (1991) Structure, biosynthesis and biological roles of monocyte-macrophage colony stimulating factor (CSF-1 or M-CSF). Nouv. Rev. Fr. Hematol. 33, 323-333
26. Price, L.K., Choi, H.U., Rosenberg, L. and Stanley, E.R. (1992) The predominant form of secreted colony stimulating factor-1 is a proteoglycan. J. Biol. Chem. 267, 2190-2199
27. Wiktor-Jedrzejczak, W., Bartocci, A., Ferrante, A.W. Jr., Ahmed-Ansari, A., Sell, K.W., Pollard, J.W. and Stanley, E.R. (1990) Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc. Natl. Acad. Sci. U.S.A. 87, 4828-4832
28. Dai, X.M., Ryan, G.R., Hapel, A.J., Dominguez, M.G., Russell, R.G., Kapp, S., Sylvestre, V. and Stanley, E.R. (2002) Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99, 111-120
29. Niida, S., Kaku, M., Amano, H., Yoshida, H., Kataoka, H., Nishikawa, S., Tanne, K., Maeda, N., Nishikawa, S. and Kodama, H. (1999) Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J. Exp. Med. 190, 293-298
30. Wiktor-Jedrzejczak, W. and Gordon, S. (1996) Cytokine regulation of the macrophage (M phi) system studied using the colony stimulating factor-1-deficient op/op mouse. Physiol. Rev. 76, 927-947
31. Nandi, S., Gokhan, S., Dai, X.M., Wei, S., Enikolopov, G., Lin, H., Mehler, M.F. and Stanley, E.R. (2012) The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation. Dev. Biol. 367, 100-113
32. Nandi, S., Cioce, M., Yeung, Y.G., Nieves, E., Tesfa, L., Lin, H., Hsu, A.W., Halenbeck, R., Cheng, H.Y., Gokhan, S. et al. (2013) Receptor-type protein-tyrosine phosphatase zeta is a functional receptor for interleukin-34. J. Biol. Chem. 288, 21972-21986
33. Ulbricht, U., Eckerich, C., Fillbrandt, R., Westphal, M. and Lamszus, K. (2006) RNA interference targeting protein tyrosine phosphatase zeta/receptor-type protein tyrosine phosphatase beta suppresses glioblastoma growth in vitro and in vivo. J. Neurochem. 98, 1497-1506
34. Wang, Y., Szretter, K.J., Vermi, W., Gilfillan, S., Rossini, C., Cella, M., Barrow, A.D., Diamond, M.S. and Colonna, M. (2012) IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat. Immunol. 13, 753-760
35. Kacinski, B.M. (1997) CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract. Mol. Reprod. Dev. 46, 71-74
36. Tang, R., Beuvon, F., Ojeda, M., Mosseri, V., Pouillart, P. and Scholl, S. (1992) M-CSF (monocyte colony stimulating factor) and M-CSF receptor expression by breast tumour cells: M-CSF mediated recruitment of tumour infiltrating monocytes? J. Cell. Biochem. 50, 350-356
37. Kirma, N., Hammes, L.S., Liu, Y.G., Nair, H.B., Valente, P.T., Kumar, S., Flowers, L.C. and Tekmal, R.R. (2007) Elevated expression of the oncogene c-fms and its ligand, the macrophage colony-stimulating factor-1, in cervical cancer and the role of transforming growth factor-beta1 in inducing c-fms expression. Cancer Res. 67, 1918-1926
38. Lamprecht, B., Walter, K., Kreher, S., Kumar, R., Hummel, M., Lenze, D., Kochert, K., Bouhlel, M.A., Richter, J., Soler, E. et al. (2010) Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nat. Med. 16, 571-599, , 1p following 579
39. Skrzypski, M., Dziadziuszko, R., Jassem, E., Szymanowska-Narloch, A., Gulida, G., Rzepko, R., Biernat, W., Taron, M., Jelitto-Gorska, M., Marjanski, T. et al. (2013) Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes. Clin. Lung. Cancer 14, 666-673.e2
40. Tamimi, R.M., Brugge, J.S., Freedman, M.L., Miron, A., Iglehart, J.D., Colditz, G.A. and Hankinson, S.E. (2008) Circulating colony stimulating factor-1 and breast cancer risk. Cancer Res. 68, 18-21
41. Aharinejad, S., Salama, M., Paulus, P., Zins, K., Berger, A. and Singer, C.F. (2013) Elevated CSF1 serum concentration predicts poor overall survival in women with early breast cancer. Endocr. Relat. Cancer 20, 777-783
42. Suzuki, M., Kobayashi, H., Ohwada, M., Terao, T. and Sato, I. (1998) Macrophage colony-stimulating factor as a marker for malignant germ cell tumors of the ovary. Gynecol. Oncol. 68, 35-37
43. Suzuki, M., Tamura, N., Kobayashi, H., Ohwada, M., Terao, T. and Sato, I. (2000) Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary. Gynecol. Oncol. 77, 405-409
44. Mroczko, B., Szmitkowski, M. and Okulczyk, B. (2002) Granulocyte-colony stimulating factor (G-CSF) and macrophagecolony stimulating factor (M-CSF) in colorectal cancer patients. Clin. Chem. Lab. Med. 40, 351-355
45. Mroczko, B., Groblewska, M., Wereszczynska-Siemiatkowska, U., Okulczyk, B., Kedra, B., Laszewicz, W., Dabrowski, A. and Szmitkowski, M. (2007) Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis. Clin. Chim. Acta 380, 208-212
46. Groblewska, M., Mroczko, B., Wereszczynska-Siemiatkowska, U., Mysliwiec, P., Kedra, B. and Szmitkowski, M. (2007) Serum levels of granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in pancreatic cancer patients. Clin. Chem. Lab. Med. 45, 30-34
47. Moreau, A., Praloran, V., Berrada, L., Coupey, L. and Gaillard, F. (1992) Immunohistochemical detection of cells positive for colony-stimulating factor 1 in lymph nodes from reactive lymphadenitis, and Hodgkin's disease. Leukemia 6, 126-130
48. Kowalska, M., Tajer, J., Chechlinska, M., Fuksiewicz, M., Kotowicz, B., Kaminska, J. and Walewski, J. (2012) Serum macrophage colony-stimulating factor (M-CSF) in patients with Hodgkin lymphoma. Med. Oncol. 29, 2143-2147
49. Kowalska, M., Tajer, J., Chechlinska, M., Fuksiewicz, M., Kotowicz, B., Syczewska, M., Walewski, J. and Kaminska, J. (2012) Discriminant analysis involving serum cytokine levels and prediction of the response to therapy of patients with Hodgkin lymphoma. Tumour Biol. 33, 1733-1738
50. Sapi, E. (2004) The role of CSF-1 in normal physiology of mammary gland and breast cancer: an update. Exp. Biol. Med. (Maywood) 229, 1-11
51. Rohrschneider, L.R., Rothwell, V.M. and Nicola, N.A. (1989) Transformation of murine fibroblasts by a retrovirus encoding the murine c-fms proto-oncogene. Oncogene 4, 1015-1022
52. Kacinski, B.M., Scata, K.A., Carter, D., Yee, L.D., Sapi, E., King, B.L., Chambers, S.K., Jones, M.A., Pirro, M.H., Stanley, E.R. et al. (1991) FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro. Oncogene6, 941-952
53. Scholl, S.M., Pallud, C., Beuvon, F., Hacene, K., Stanley, E.R., Rohrschneider, L., Tang, R., Pouillart, P. and Lidereau, R. (1994) Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J. Natl. Cancer Inst. 86, 120-126
54. Scholl, S.M., Mosseri, V., Tang, R., Beuvon, F., Palud, C., Lidereau, R. and Pouillart, P. (1993) Expression of colony-stimulating factor-1 and its receptor (the protein product of c-fms) in invasive breast tumor cells. Induction of urokinase production via this pathway? Ann. N.Y. Acad. Sci. 698, 131-135
55. Kluger, H.M., Dolled-Filhart, M., Rodov, S., Kacinski, B.M., Camp, R.L. and Rimm, D.L. (2004) Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis. Clin. Cancer Res. 10 (1 Pt 1), 173-177
56. Lin, E.Y., Nguyen, A.V., Russell, R.G. and Pollard, J.W. (2001) Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193, 727-740
57. Yee, L.D. and Liu, L. (2000) The constitutive production of colony stimulating factor 1 by invasive human breast cancer cells. Anticancer Res. 20 (6b), 4379-4383
58. Wyckoff, J., Wang, W., Lin, E.Y., Wang, Y., Pixley, F., Stanley, E.R., Graf, T., Pollard, J.W., Segall, J. and Condeelis, J. (2004) A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 64, 7022-7029
59. Maher, M.G., Sapi, E., Turner, B., Gumbs, A., Perrotta, P.L., Carter, D., Kacinski, B.M. and Haffty, B.G. (1998) Prognostic significance of colony-stimulating factor receptor expression in ipsilateral breast cancer recurrence. Clin. Cancer Res. 4, 1851-1856
60. Aharinejad, S., Paulus, P., Sioud, M., Hofmann, M., Zins, K., Schafer, R., Stanley, E.R. and Abraham, D. (2004) Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice. Cancer Res. 64, 5378-5384
61. Lin, E.Y., Li, J.F., Gnatovskiy, L., Deng, Y., Zhu, L., Grzesik, D.A., Qian, H., Xue, X.N. and Pollard, J.W. (2006) Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 66, 11238-11246
62. Lee, P.S., Wang, Y., Dominguez, M.G., Yeung, Y.G., Murphy, M.A., Bowtell, D.D. and Stanley, E.R. (1999) The Cbl protooncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation. EMBO J. 18, 3616-3628
63. Lewis, C.E. and Pollard, J.W. (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66, 605-612
64. Paulus, P., Stanley, E.R., Schafer, R., Abraham, D. and Aharinejad, S. (2006) Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts. Cancer Res. 66, 4349-4356
65. Sorrentino, A., Liu, C.G., Addario, A., Peschle, C., Scambia, G. and Ferlini, C. (2008) Role of microRNAs in drug-resistant ovarian cancer cells. Gynecol. Oncol. 111, 478-486
66. Barbetti, V., M.A., Tusa I., Digiacomo, G., Riverso, M., Marzi, I., Cipolleschi, M.G., Bessi, S., Giannini, A., Di Leo, A., Dello Sbarba, P. and Rovida, E. (2014) Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells. Oncogene 33, 4359-4364
67. Barbetti, V., Morandi, A., Tusa, I., Digiacomo, G., Riverso, M., Marzi, I., Cipolleschi, M.G., Bessi, S., Giannini, A., Di Leo, A. et al. (2014) Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells. Oncogene 33, 4359-4364
68. Chambers, S.K., Kacinski, B.M., Ivins, C.M. and Carcangiu, M.L. (1997) Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Clin. Cancer Res. 3, 999-1007
69. Scholl, S.M., Bascou, C.H., Mosseri, V., Olivares, R., Magdelenat, H., Dorval, T., Palangie, T., Validire, P., Pouillart, P. and Stanley, E.R. (1994) Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer. Br. J. Cancer 69, 342-346
70. Price, F.V., Chambers, S.K., Chambers, J.T., Carcangiu, M.L., Schwartz, P.E., Kohorn, E.I., Stanley, E.R. and Kacinski, B.M. (1993) Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival. Am. J. Obstet. Gynecol. 168, 520-527
71. Skates, S.J., Horick, N., Yu, Y., Xu, F.J., Berchuck, A., Havrilesky, L.J., de Bruijn, H.W., van der Zee, A.G., Woolas, R.P., Jacobs, I.J. et al. (2004) Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions. J. Clin. Oncol. 22, 4059-4066
72. Toy, E.P., Azodi, M., Folk, N.L., Zito, C.M., Zeiss, C.J. and Chambers, S.K. (2009) Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colony-stimulating factor. Neoplasia 11, 136-144
73. Chambers, S.K., Wang, Y., Gertz, R.E. and Kacinski, B.M. (1995) Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase. Cancer Res. 55, 1578-1585
74. Chambers, S.K., Ivins, C.M. and Carcangiu, M.L. (1998) Plasminogen activator inhibitor-1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients. Int. J. Cancer 79, 449-454
75. Kuhn, W., Schmalfeldt, B., Reuning, U., Pache, L., Berger, U., Ulm, K., Harbeck, N., Spathe, K., Dettmar, P., Hofler, H. et al. (1999) Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc. Br. J. Cancer 79, 1746-1751
76. Wilhelm, O., Schmitt, M., Hohl, S., Senekowitsch, R. and Graeff, H. (1995) Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice. Clin. Exp. Metastasis 13, 296-302
77. Baiocchi, G., Kavanagh, J.J., Talpaz, M., Wharton, J.T., Gutterman, J.U. and Kurzrock, R. (1991) Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies. Cancer 67, 990-996
78. Steidl, C., Lee, T., Shah, S.P., Farinha, P., Han, G., Nayar, T., Delaney, A., Jones, S.J., Iqbal, J., Weisenburger, D.D. et al. (2010) Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl. J. Med. 362, 875-885
79. Paietta, E., Racevskis, J., Stanley, E.R., Andreeff, M., Papenhausen, P. and Wiernik, P.H. (1990) Expression of the macrophage growth factor, CSF-1 and its receptor c-fms by a Hodgkin's disease-derived cell line and its variants. Cancer Res. 50, 2049-2055
80. Janowska-Wieczorek, A., Belch, A.R., Jacobs, A., Bowen, D., Padua, R.A., Paietta, E. and Stanley, E.R. (1991) Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies. Blood 77, 1796-1803
81. Kitagawa, D., Gouda, M., Kirii, Y., Sugiyama, N., Ishihama, Y., Fujii, I., Narumi, Y., Akita, K. and Yokota, K. (2012) Characterization of kinase inhibitors using different phosphorylation states of colony stimulating factor 1 receptor tyrosine kinase. J. Biochem. 151, 47-55
82. Burns, C.J. and Wilks, W.A. (2011) c-FMS inhibitors: a patent review. Expert Opin. Ther. Patents 21, 147-165
83. Patel, S. and Player, M.R. (2009) Colony-stimulating factor-1 receptor inhibitors for the treatment of cancer and inflammatory disease. Curr. Top. Med. Chem. 9, 599-610
84. Karaman, M.W., Herrgard, S., Treiber, D.K., Gallant, P., Atteridge, C.E., Campbell, B.T., Chan, K.W., Ciceri, P., Davis, M.I., Edeen, P.T. et al. (2008) A quantitative analysis of kinase inhibitor selectivity. Nat. Biotechnol. 26, 127-132
85. Brownlow, N., Vaid, M. and Dibb, N.J. (2008) Tandutinib inhibits FMS receptor signalling, and macrophage and osteoclast formation in vitro. Leukemia 22, 1452-1453
86. Blay, J.Y., El Sayadi, H., Thiesse, P., Garret, J. and Ray-Coquard, I. (2008) Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT). Ann. Oncol. 19, 821-822
87. Dewar, A.L., Cambareri, A.C., Zannettino, A.C., Miller, B.L., Doherty, K.V., Hughes, T.P. and Lyons, A.B. (2005) Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib. Blood 105, 3127-3132
88. Cassier, P.A., Gelderblom, H., Stacchiotti, S., Thomas, D., Maki, R.G., Kroep, J.R., van der Graaf, W.T., Italiano, A., Seddon, B., Domont, J. et al. (2012) Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis. Cancer 118, 1649-1655
89. Gelderblom, H., Pérol, D., Chevreau, C., Tattersall, M., Stacchiotti, S., Casali, P., Cropet, C., Piperno-Neumann, S., Le Cesne, A., Italiano, A. et al. (2013) An open-label international multicentric phase II study of nilotinib in progressive pigmented villo-nodular synovitis (PVNS) not amenable to a conservative surgical treatment. Proc. Am. Soc. Clon. Oncol. 31 (suppl), abstr 10516
90. Stacchiotti, S., Crippa, F., Messina, A., Pilotti, S., Gronchi, A., Blay, J.Y. and Casali, P.G. (2013) Response to imatinib in villonodular pigmented synovitis (PVNS) resistant to nilotinib. Clin. Sarcoma Res. 3, 8
91. Ries, C.H., Cannarile, M.A., Hoves, S., Benz, J., Wartha, K., Runza, V., Rey-Giraud, F., Pradel, L.P., Feuerhake, F., Klaman, I. et al. (2014) Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell 25, 846-859
92. Gomez-Roca, C.A., Cassier, P.A., Italiano, A., Cannarile, M., Ries, C., Brillouet, A., Mueller, C., Jegg, A., Meneses-Lorente, G., Baehner, M. et al. (2015) Phase I study of RG7155, a novel anti-CSF1R antibody, in patients with advanced/metastatic solid tumors. J. Clin. Oncol. 33 (suppl), abstr 3005